Colorado lawmakers are floating a bill to cap the cost of epinephrine autoinjectors, commonly known as EpiPens, Colorado Public Radio reported Jan. 11.
The bill would allow uninsured residents to purchase the devices at $60 or less for a two-pack. The bill would also cap the price at a $60 copay for the commercially insured.
The Colorado Association of Health Plans has not taken a position on the proposal, according to Colorado Public Radio.
Amanda Massey, the association's executive director, told the station copay caps do not reduce the actual cost of any drug.
"Coloradans deserve access to affordable, life-saving medications and this bill only hides the outrageous prices set by Big Pharma and forces all Coloradans to pay for it through increased health insurance premiums," Ms. Massey said.